← Eichor
Condition: Restenoses Coronary Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Restenoses Coronary

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06845410Disease Characteristics of IR-CAD: a Case-control Study
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06007248Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.
Phase N/A · 1 location(s) · Olivier F. Bertrand · NCT06972225Abbott Vascular Medical Device Registry
Phase N/A · 37 location(s) · Abbott Medical Devices · NCT04573660Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angio
NA · 5 location(s) · Deutsches Herzzentrum Muenchen · NCT05544864COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLE
Phase N/A · 1 location(s) · Luzerner Kantonsspital · NCT06075602Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT05860400SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With
Phase N/A · 1 location(s) · Luzerner Kantonsspital · NCT04988685
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.